Skip to main content
. 2018 Apr 13;97(15):e0416. doi: 10.1097/MD.0000000000010416

Figure 2.

Figure 2

Dynamic trends of HCV RNA viral load and anti-HCV antibody after treatment with SOF and DCV of the patient: HCV RNA viral load was undetectable at weeks 4, and anti-HCV antibody underwent seroconversion at weeks 12. The patient achieved SVR 36 weeks after the end of treatment. DCV = daclatasvir, HCV = hepatitis C virus, SOF = sofosbuvir.